- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 160
Mitsui and Siemens fuel $60m series D for Lanzatech
The sustainable energy and fuels producer has raised $60m in a round also featuring the corporate venturing arms of Siemens and CICC.
Mar 27, 2014GE Pension Trust helps Verdasys unlock funding
Data security firm Verdasys has taken its overall funding past $65m with a round backed by GE Pension Trust
Mar 25, 2014Alibaba joins the Tango dance with $215m investment
The free mobile communication service, which has secured funding from Qualcomm and Access Industries in the past, has raised $280m in its latest venture round.
Mar 21, 2014LED lighting company Glo closes $30m series D round
The Sweden-based company, which uses nanotechnology to develop next-generation lighting products, counts Agder Energi Ventures among its existing investors.
Mar 20, 2014Novo leads ZSPharma to better health
ZS Pharma, a specialty pharmaceutical company developing novel treatments for kidney, cardiovascular, and liver disorders, has completed a $55m series D financing. The investor syndicate was led by Novo A/S and included new investors RA Capital, Adage Capital, Sofinnova Ventures ,and an undisclosed institutional investor. The company has raised $103m to date.
Mar 15, 2014Susquehanna leads Payoneer funding
Online payments company Payoneer raises series D financing round of $25m, led by Susquehanna Growth Equity, to "transform the way small businesses around the world get paid for selling products and services across borders".
Mar 11, 2014EBay back for Snapdeal
Online marketplace eBay leads $133.8m in series D funding for Indian peer Snapdeal.com.
Mar 4, 2014JAIC, Nippon treat Regimmune to $9.2m series D
Japan Asia Investment Corporation (JAIC) and Nippon Venture Capital Corp (NVCC) have led a $9.2m series D round of funding for Regimmune, a Japanese biotechnology company focused on the discovery, development and commercialisation of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, auto-immune diseases and transplantation.
Feb 20, 2014Johnson & Johnson eyes another round for PowerVision
Existing investors Venrock, Johnson & Johnson Development Corp., Medtronic, Advanced Technology Ventures, Lexington Capital and Frazier Healthcare Ventures have invested in a first tranche of a series D round of funding for PowerVision. The company is developing an accommodating intraocular lens. The company plans to raise up to an additional $10m as part of this $20m financing round.
Feb 11, 2014About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


